Search research articles
Contact Us
Filters
Showing results (71-80 of 402) with videos related to
Page
of 41
Sort By:
Cardiovascular Research
|
June 14, 2005
Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction
Daniela Fraccarollo, Paolo Galuppo, Isabel Schmidt, et al.
Biochemical Pharmacology
|
May 28, 2004
Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats
Andreas Schäfer, Julian Widder, Martin Eigenthaler, et al.
Journal of Cardiovascular Pharmacology
|
June 16, 2006
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts
Jens A Wagner, Marco Abesser, Judith Harvey-White, et al.
Cardiovascular Research
|
June 14, 2002
Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy
Daniela Fraccarollo, Johann Bauersachs, Markus Kellner, et al.
International Journal of Cardiology
|
August 2, 2005
Effects of ischemia on myocardial function during rapid left ventricular pacing
Anil M Sinha, Ole A Breithardt, Dorothée Sinha, et al.
Trends in Cardiovascular Medicine
|
February 24, 2009
Sleep-disordered breathing and heart failure a dangerous liaison
Susanne Brenner, Christiane Angermann, Berthold Jany, et al.
BMC Medical Genetics
|
July 20, 2016
Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles
Daniel Oder, Dorothee Vergho, Georg Ertl, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 20, 2015
Fabry disease and the heart
Nora Seydelmann, Christoph Wanner, Stefan Störk, et al.
Autoimmunity
|
September 11, 2008
Pathological autoantibodies in cardiomyopathy
Roland Jahns, Valérie Boivin, Valentin Schwarzbach, et al.
JACC. Heart Failure
|
February 4, 2026
REPLY: CMR-First in Newly Diagnosed HFrEF: Specificity, Reference Standards, and the Value of Integrated Assessment
Gülmisal Güder, Wolfgang R Bauer, Stefan Frantz, et al.
Page
of 41
Search research articles
Search
Showing results (71-80 of 402) with videos related to
Sort By:
Page
of 41
Cardiovascular Research
|
June 14, 2005
Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction
Daniela Fraccarollo, Paolo Galuppo, Isabel Schmidt, et al.
Biochemical Pharmacology
|
May 28, 2004
Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats
Andreas Schäfer, Julian Widder, Martin Eigenthaler, et al.
Journal of Cardiovascular Pharmacology
|
June 16, 2006
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts
Jens A Wagner, Marco Abesser, Judith Harvey-White, et al.
Cardiovascular Research
|
June 14, 2002
Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy
Daniela Fraccarollo, Johann Bauersachs, Markus Kellner, et al.
International Journal of Cardiology
|
August 2, 2005
Effects of ischemia on myocardial function during rapid left ventricular pacing
Anil M Sinha, Ole A Breithardt, Dorothée Sinha, et al.
Trends in Cardiovascular Medicine
|
February 24, 2009
Sleep-disordered breathing and heart failure a dangerous liaison
Susanne Brenner, Christiane Angermann, Berthold Jany, et al.
BMC Medical Genetics
|
July 20, 2016
Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles
Daniel Oder, Dorothee Vergho, Georg Ertl, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 20, 2015
Fabry disease and the heart
Nora Seydelmann, Christoph Wanner, Stefan Störk, et al.
Autoimmunity
|
September 11, 2008
Pathological autoantibodies in cardiomyopathy
Roland Jahns, Valérie Boivin, Valentin Schwarzbach, et al.
JACC. Heart Failure
|
February 4, 2026
REPLY: CMR-First in Newly Diagnosed HFrEF: Specificity, Reference Standards, and the Value of Integrated Assessment
Gülmisal Güder, Wolfgang R Bauer, Stefan Frantz, et al.
Page
of 41